Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America

Myriam Arévalo-Herrera, Yezid Solarte, Catherin Marin, Mariana Santos, Jenniffer Castellanos, John C Beier, Sócrates Herrera Valencia

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Malaria is a vector-borne disease that is considered to be one of the most serious public health problems due to its high global mortality and morbidity rates. Although multiple strategies for controlling malaria have been used, many have had limited impact due to the appearance and rapid dissemination of mosquito resistance to insecticides, parasite resistance to multiple antimalarial drug, and the lack of sustainability. Individuals in endemic areas that have been permanently exposed to the parasite develop specific immune responses capable of diminishing parasite burden and the clinical manifestations of the disease, including blocking of parasite transmission to the mosquito vector. This is referred to as transmission blocking (TB) immunity (TBI) and is mediated by specific antibodies and other factors ingested during the blood meal that inhibit parasite development in the mosquito. These antibodies recognize proteins expressed on either gametocytes or parasite stages that develop in the mosquito midgut and are considered to be potential malaria vaccine candidates. Although these candidates, collectively called TB vaccines (TBV), would not directly stop malaria from infecting individuals, but would stop transmission from infected person to non-infected person. Here, we review the progress that has been achieved in TBI studies and the development of TBV and we highlight their potential usefulness in areas of low endemicity such as Latin America.

Original languageEnglish
Pages (from-to)202-211
Number of pages10
JournalMemorias do Instituto Oswaldo Cruz
Volume106
Issue numberSUPPL. 1
DOIs
StatePublished - Aug 1 2011

Fingerprint

Malaria Vaccines
Latin America
Malaria
Immunity
Parasites
Culicidae
Vaccines
Insecticide Resistance
Disease Vectors
Antibodies
Antimalarials
Meals
Public Health
Morbidity
Mortality

Keywords

  • Malaria
  • Plasmodium
  • Transmission blocking immunity
  • Transmission blocking vaccine
  • Vaccines
  • Vector-borne disease

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. / Arévalo-Herrera, Myriam; Solarte, Yezid; Marin, Catherin; Santos, Mariana; Castellanos, Jenniffer; Beier, John C; Valencia, Sócrates Herrera.

In: Memorias do Instituto Oswaldo Cruz, Vol. 106, No. SUPPL. 1, 01.08.2011, p. 202-211.

Research output: Contribution to journalArticle

Arévalo-Herrera, Myriam ; Solarte, Yezid ; Marin, Catherin ; Santos, Mariana ; Castellanos, Jenniffer ; Beier, John C ; Valencia, Sócrates Herrera. / Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. In: Memorias do Instituto Oswaldo Cruz. 2011 ; Vol. 106, No. SUPPL. 1. pp. 202-211.
@article{55828a7f173648898b03b6f0526ec086,
title = "Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America",
abstract = "Malaria is a vector-borne disease that is considered to be one of the most serious public health problems due to its high global mortality and morbidity rates. Although multiple strategies for controlling malaria have been used, many have had limited impact due to the appearance and rapid dissemination of mosquito resistance to insecticides, parasite resistance to multiple antimalarial drug, and the lack of sustainability. Individuals in endemic areas that have been permanently exposed to the parasite develop specific immune responses capable of diminishing parasite burden and the clinical manifestations of the disease, including blocking of parasite transmission to the mosquito vector. This is referred to as transmission blocking (TB) immunity (TBI) and is mediated by specific antibodies and other factors ingested during the blood meal that inhibit parasite development in the mosquito. These antibodies recognize proteins expressed on either gametocytes or parasite stages that develop in the mosquito midgut and are considered to be potential malaria vaccine candidates. Although these candidates, collectively called TB vaccines (TBV), would not directly stop malaria from infecting individuals, but would stop transmission from infected person to non-infected person. Here, we review the progress that has been achieved in TBI studies and the development of TBV and we highlight their potential usefulness in areas of low endemicity such as Latin America.",
keywords = "Malaria, Plasmodium, Transmission blocking immunity, Transmission blocking vaccine, Vaccines, Vector-borne disease",
author = "Myriam Ar{\'e}valo-Herrera and Yezid Solarte and Catherin Marin and Mariana Santos and Jenniffer Castellanos and Beier, {John C} and Valencia, {S{\'o}crates Herrera}",
year = "2011",
month = "8",
day = "1",
doi = "10.1590/S0074-02762011000900025",
language = "English",
volume = "106",
pages = "202--211",
journal = "Memorias do Instituto Oswaldo Cruz",
issn = "0074-0276",
publisher = "Fundacao Oswaldo Cruz",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America

AU - Arévalo-Herrera, Myriam

AU - Solarte, Yezid

AU - Marin, Catherin

AU - Santos, Mariana

AU - Castellanos, Jenniffer

AU - Beier, John C

AU - Valencia, Sócrates Herrera

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Malaria is a vector-borne disease that is considered to be one of the most serious public health problems due to its high global mortality and morbidity rates. Although multiple strategies for controlling malaria have been used, many have had limited impact due to the appearance and rapid dissemination of mosquito resistance to insecticides, parasite resistance to multiple antimalarial drug, and the lack of sustainability. Individuals in endemic areas that have been permanently exposed to the parasite develop specific immune responses capable of diminishing parasite burden and the clinical manifestations of the disease, including blocking of parasite transmission to the mosquito vector. This is referred to as transmission blocking (TB) immunity (TBI) and is mediated by specific antibodies and other factors ingested during the blood meal that inhibit parasite development in the mosquito. These antibodies recognize proteins expressed on either gametocytes or parasite stages that develop in the mosquito midgut and are considered to be potential malaria vaccine candidates. Although these candidates, collectively called TB vaccines (TBV), would not directly stop malaria from infecting individuals, but would stop transmission from infected person to non-infected person. Here, we review the progress that has been achieved in TBI studies and the development of TBV and we highlight their potential usefulness in areas of low endemicity such as Latin America.

AB - Malaria is a vector-borne disease that is considered to be one of the most serious public health problems due to its high global mortality and morbidity rates. Although multiple strategies for controlling malaria have been used, many have had limited impact due to the appearance and rapid dissemination of mosquito resistance to insecticides, parasite resistance to multiple antimalarial drug, and the lack of sustainability. Individuals in endemic areas that have been permanently exposed to the parasite develop specific immune responses capable of diminishing parasite burden and the clinical manifestations of the disease, including blocking of parasite transmission to the mosquito vector. This is referred to as transmission blocking (TB) immunity (TBI) and is mediated by specific antibodies and other factors ingested during the blood meal that inhibit parasite development in the mosquito. These antibodies recognize proteins expressed on either gametocytes or parasite stages that develop in the mosquito midgut and are considered to be potential malaria vaccine candidates. Although these candidates, collectively called TB vaccines (TBV), would not directly stop malaria from infecting individuals, but would stop transmission from infected person to non-infected person. Here, we review the progress that has been achieved in TBI studies and the development of TBV and we highlight their potential usefulness in areas of low endemicity such as Latin America.

KW - Malaria

KW - Plasmodium

KW - Transmission blocking immunity

KW - Transmission blocking vaccine

KW - Vaccines

KW - Vector-borne disease

UR - http://www.scopus.com/inward/record.url?scp=80051766424&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051766424&partnerID=8YFLogxK

U2 - 10.1590/S0074-02762011000900025

DO - 10.1590/S0074-02762011000900025

M3 - Article

C2 - 21881775

AN - SCOPUS:80051766424

VL - 106

SP - 202

EP - 211

JO - Memorias do Instituto Oswaldo Cruz

JF - Memorias do Instituto Oswaldo Cruz

SN - 0074-0276

IS - SUPPL. 1

ER -